We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

203 hedge funds and large institutions have $2.05B invested in Bio-Rad Laboratories Class A in 2013 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $353K

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

31% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 62

3% more funds holding

Funds holding: 198203 (+5)

4% more capital invested

Capital invested by funds: $1.97B → $2.05B (+$77.9M)

0.36% less ownership

Funds ownership: 75.05%74.69% (-0.36%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
203
Holders Change
+5
Holders Change %
+2.53%
% of All Funds
6.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
27
Increased
81
Reduced
62
Closed
20
Calls
$1.54M
Puts
$353K
Net Calls
+$1.19M
Net Calls Change
+$222K
Name Holding Trade Value Shares
Change
Change in
Stake
HNB
151
Huntington National Bank
Ohio
$348K -$22.4K -190 -6%
RFC
152
Regions Financial Corp
Alabama
$340K +$104K +878 +43%
FIM
153
Freedom Investment Management
Connecticut
$339K -$2.95K -25 -0.9%
COPPSERS
154
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$334K -$4.83K -41 -1%
BlackRock
155
BlackRock
New York
$331K +$7.19K +61 +2%
NG
156
NatWest Group
United Kingdom
$330K +$331K +2,808 New
Schroder Investment Management Group
157
Schroder Investment Management Group
United Kingdom
$329K -$826K -7,000 -71%
BUB
158
BBVA USA Bancshares
Texas
$319K +$30.2K +256 +10%
SB
159
Suntrust Banks
Georgia
$318K -$1.77M -14,977 -85%
PP
160
PDT Partners
New York
$317K -$692K -5,869 -68%
BA
161
BlackRock Advisors
Delaware
$317K -$9.44K -80 -3%
OI
162
Oakbrook Investments
Illinois
$316K -$59K -500 -16%
CAM
163
Capstone Asset Management
Texas
$314K +$315K +2,670 New
ZCM
164
Zebra Capital Management
Connecticut
$313K -$70.1K -594 -18%
Teacher Retirement System of Texas
165
Teacher Retirement System of Texas
Texas
$302K +$144K +1,221 +90%
LIM
166
Leavell Investment Management
Alabama
$294K
YMRC
167
Yorktown Management & Research Company
Virginia
$294K
WAM
168
World Asset Management
Michigan
$271K -$47.3K -401 -15%
SCM
169
Shelton Capital Management
Colorado
$269K
ProShare Advisors
170
ProShare Advisors
Maryland
$268K +$269K +2,278 New
OA
171
OFI Advisors
Pennsylvania
$242K +$7.78K +66 +3%
DADC
172
D.A. Davidson & Co
Montana
$239K +$17.8K +151 +8%
CONA
173
Capital One National Association
New York
$238K +$9.08K +77 +4%
BKBG
174
BHF Kleinwort Benson Group
Belgium
$229K +$230K +1,950 New
FCBT
175
First Citizens Bank & Trust
North Carolina
$227K +$7.19K +61 +3%

BIO Hedge Fund Activity: Q3 2013 in Review

203 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2013, worth a combined $2.05B — up 3.9% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BIO positions and 20 closed out — a net gain of 7 holders — while 81 added to existing stakes and 62 trimmed.

The largest buyer was American Century Companies, opening a new position worth an estimated $29.6M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $72.6M.

  • 203 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2013, up from 198 in Q2 2013.
  • Funds reported $2.05B of Bio-Rad Laboratories Class A stock for Q3 2013, up 3.9% quarter-over-quarter.
  • 27 funds opened new Bio-Rad Laboratories Class A positions in Q3 2013 and 20 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2013 was American Century Companies, an estimated $29.6M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2013 was Brown Brothers Harriman & Co, an estimated $72.6M sold.

Based on aggregated 13F filings for Q3 2013.